A pig kidney with one genetic change functioned in a brain-dead human for 61 days, more than doubling previous records.

H OUSTON -- A novel self-administered shot that inhibits two key immunoregulatory cytokines reduced proteinuria in patients ...

Not taking enough vitamin D can cause more harm than you’ve heard. Take the risk to heart health, for example. But no worries ...

The pathogenesis of arterial hypertension often involves a rise in systemic vascular resistance (vasoconstriction and vascular remodeling) and impairment of salt excretion in the kidney (inappropriate ...

A polypill containing three recommended heart failure therapies improved heart function, reduced hospitalizations and was ...

Combined capital will support the ongoing Phase 2a clinical trial of procizumab in cardiogenic shock Hennigsdorf/Berlin, November 13, 2025 – 4TEEN4 Pharmaceuticals GmbH (“4TEEN4”) today announced the ...

U rinary albumin-creatinine ratio (UACR) may be slightly better than urinary protein-creatinine ratio (UPCR) at predicting kidney failure-related clinical outcomes in chronic kidney disease (CKD), a ...

Povetacicept is an investigational dual BAFF and APRIL inhibitor being tested for various glomerulonephritis types in clinical trials.

Cancer treatments can exert cardiotoxic effects, but screening and monitoring can detect and minimize cancer therapy-related ...

Treatment with telitacicept for 39 weeks resulted in a rapid, clinically meaningful, and statistically significant reduction in proteinuria, with ...

The results of high-impact phase 3 clinical trials that could affect kidney-related medical care will be presented in-person at American Society of Nephrology Kidney Week 2025 November 5–9.

The combination therapy improved LVEF, quality of life, clinical outcomes, and more, but implementation questions remain.